P1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS

• M. Hao,
• D. Yin,
• Y. Li,
• Y. Gi,
• J. Tian,
• H. Guo,
• D. Fan,
• W. Qin,
• Q. Liu,
• W. Wang,
• L. Li,
• Z. Peng,
• L. Liu

Affiliations

M. Hao

1 Hematology, Tangdu Hospital, Fourth Military Medical University

D. Yin

1 Hematology, Tangdu Hospital, Fourth Military Medical University

Y. Li

1 Hematology, Tangdu Hospital, Fourth Military Medical University

Y. Gi

1 Hematology, Tangdu Hospital, Fourth Military Medical University

J. Tian

1 Hematology, Tangdu Hospital, Fourth Military Medical University

H. Guo

1 Hematology, Tangdu Hospital, Fourth Military Medical University

D. Fan

1 Hematology, Tangdu Hospital, Fourth Military Medical University

W. Qin

1 Hematology, Tangdu Hospital, Fourth Military Medical University

Q. Liu

1 Hematology, Tangdu Hospital, Fourth Military Medical University

W. Wang

1 Hematology, Tangdu Hospital, Fourth Military Medical University

L. Li

2 Sunnycell Therapeutics Co., Ltd

Z. Peng

2 Sunnycell Therapeutics Co., Ltd

L. Liu

1 Hematology, Tangdu Hospital, Fourth Military Medical University